0.4400
+0.0550
+(14.29%)
At close: 4:10:57 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-10,120
-10,120
-12,451
9,806
4,195
Investing Cash Flow
-4,791
-4,791
-8,094
-2,989
-4,979
Financing Cash Flow
34,815
34,815
-23
-101
-190
End Cash Position
36,252
36,252
16,349
36,897
30,121
Interest Paid Supplemental Data
35
35
1
19
36
Capital Expenditure
-4,791
-4,791
-8,094
-2,989
-4,979
Issuance of Capital Stock
37,522
37,522
11
273
163
Repurchase of Capital Stock
-2,530
-2,530
-1
-9
-12
Free Cash Flow
-14,911
-14,911
-20,545
6,817
-784
6/30/2021 - 3/30/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
WFL.AX Wellfully Limited
0.0030
0.00%
PEB.AX Pacific Edge Limited
0.1100
-4.35%
CTE.AX Cryosite Limited
0.7950
0.00%
MAP.AX Microba Life Sciences Limited
0.1850
-2.63%
GTG.AX Genetic Technologies Limited
0.0390
0.00%
RHY.AX Rhythm Biosciences Limited
0.0800
+1.27%
IIQ.AX INOVIQ Ltd
0.3700
-7.50%
BDX.AX BCAL Diagnostics Limited
0.0940
+5.62%
IBX.AX Imagion Biosystems Limited
0.0140
0.00%
ACL.AX Australian Clinical Labs Limited
2.9800
+1.02%